Kintegral Advisory’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.09M	Sell	63,507 -2,816	-4%	-$232K	0.48%	51
2025 Q4	$5.65M	Sell	66,323 -1,815	-3%	-$149K	0.48%	52
2025 Q3	$5.3M	Sell	68,138 -305	-0.4%	-$23.8K	0.45%	62
2025 Q2	$5.35M	Sell	68,443 -103	-0.2%	-$7.68K	0.49%	58
2025 Q1	$4.97M	Sell	68,546 -230	-0.3%	-$16.5K	0.5%	58
2024 Q4	$5.09M	Sell	68,776 -3,204	-4%	-$224K	0.48%	55
2024 Q3	$4.75M	Sell	71,980 -943	-1%	-$68.5K	0.44%	69
2024 Q2	$6.74M	Buy	72,923 +40,223	+123%	+$3.56M	0.65%	35
2024 Q1	$3.12M	Sell	32,700 -102	-0.3%	-$8.57K	0.31%	90
2023 Q4	$2.5M	Sell	32,802 -208	-0.6%	-$14.5K	0.28%	99
2023 Q3	$2.29M	Sell	33,010 -20	-0.1%	-$1.61K	0.28%	97
2023 Q2	$3.12M	Hold	33,030	–	–	0.37%	83
2023 Q1	$2.73M	Sell	33,030 -1,775	-5%	-$140K	0.35%	91
2022 Q4	$2.6M	Buy	34,805 +8,697	+33%	+$670K	0.34%	95
2022 Q3	$2.16M	Hold	26,108	–	–	0.3%	88
2022 Q2	$2.48M	Buy	26,108 +553	+2%	+$57.2K	0.32%	82
2022 Q1	$3.01M	Buy	25,555 +571	+2%	+$64.1K	0.33%	79
2021 Q4	$3.24M	Hold	24,984	–	–	0.34%	71
2021 Q3	$2.83M	Hold	24,984	–	–	0.33%	73
2021 Q2	$2.59M	Hold	24,984	–	–	0.31%	82
2021 Q1	$2.09M	Hold	24,984	–	–	0.27%	95
2020 Q4	$2.28M	Hold	24,984	–	–	0.31%	82
2020 Q3	$1.99M	Sell	24,984 -804	-3%	-$62.7K	0.3%	82
2020 Q2	$1.78M	Hold	25,788	–	–	0.29%	85
2020 Q1	$1.62M	Buy	25,788 +2,886	+13%	+$208K	0.32%	84
2019 Q4	$1.78M	Hold	22,902	–	–	0.32%	88
2019 Q3	$1.68M	Hold	22,902	–	–	0.33%	87
2019 Q2	$1.41M	Hold	22,902	–	–	0.29%	99
2019 Q1	$1.46M	Buy	22,902 +7,251	+46%	+$414K	0.31%	93
2018 Q4	$799K	Buy	+15,651	New	+$792K	0.24%	99